EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Cryoablation Plus Immune Checkpoint Inhibitors Enhanced Dendritic Cell and T Cell Activation in TNBC Murine Model

Flavia Sardela de Miranda iD, Rachel L Babcock, Maria F Mahecha, Prrishti J Gukhool, Geetha P Boligala, Amanda K Garcia, Dalia Martinez-Marin, Ava G Oliver, Thomas Hintelmann, Kathryn L Furr, Chhanda Bose, Sharilyn Almodovar und 4 weitere

ImmunoTargets and Therapy · 2026-04 · Volume 15 · 1-22

DOI: 10.2147/itt.s581990 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoTargets and Therapy, 2026-04. Verfasst von Flavia Sardela de Miranda und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, TX, 79430, USA. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

abscopal effectanti-tumor immune responsecryoablationimmune checkpoint inhibitorstriple-negative breast cancer

Autor:innen und Institutionen

  • Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, TX, 79430, USA.
  • Breast Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, 79430, USA.
  • Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX, 79430, USA.
  • Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
  • Department of Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, TX, 79430, USA.
  • Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, 79430, USA.

ORCID-Profile: Flavia Sardela de Miranda

Zitieren

APA

Sardela de Miranda, F., Babcock, R. L., Mahecha, M. F., Gukhool, P. J., Boligala, G. P., Garcia, A. K., Martinez-Marin, D., Oliver, A. G., Hintelmann, T., Furr, K. L., Bose, C., Almodovar, S., Singh, S. P., Pruitt, K., Melkus, M. W., & Layeequr Rahman, R. (2026). Cryoablation Plus Immune Checkpoint Inhibitors Enhanced Dendritic Cell and T Cell Activation in TNBC Murine Model. ImmunoTargets and Therapy, Volume 15, 1-22. https://doi.org/10.2147/itt.s581990

Vancouver

Sardela de Miranda F, Babcock RL, Mahecha MF, Gukhool PJ, Boligala GP, Garcia AK, et al. Cryoablation Plus Immune Checkpoint Inhibitors Enhanced Dendritic Cell and T Cell Activation in TNBC Murine Model. ImmunoTargets and Therapy. 2026;Volume 15:1-22. doi:10.2147/itt.s581990

BibTeX
@article{SardeladeMiranda2026,
  author = {Sardela de Miranda, Flavia and Babcock, Rachel L and Mahecha, Maria F and Gukhool, Prrishti J and Boligala, Geetha P and Garcia, Amanda K and Martinez-Marin, Dalia and Oliver, Ava G and Hintelmann, Thomas and Furr, Kathryn L and Bose, Chhanda and Almodovar, Sharilyn and Singh, Sharda P and Pruitt, Kevin and Melkus, Michael W and Layeequr Rahman, Rakhshanda},
  title = {Cryoablation Plus Immune Checkpoint Inhibitors Enhanced Dendritic Cell and T Cell Activation in TNBC Murine Model},
  journal = {ImmunoTargets and Therapy},
  year = {2026},
  volume = {Volume 15},
  pages = {1--22},
  doi = {10.2147/itt.s581990}
}
Kostenlos starten →